Resveratrol enhances palmitate-induced ER stress and apoptosis in cancer cells

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Rojas, Cristina ^a   Pan Castillo, Belén ^a,b   Valls, Cristina ^a   Pujadas, Gerard ^a,c   Garcia Vallve, Santi ^a,c   Arola, Lluis ^a,c   Mulero, Miquel ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c TECNIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRIACYLGLYCEROL; X BOX BINDING PROTEIN 1; ACYL COENZYME A DESATURASE; ANTINEOPLASTIC AGENT; DDIT3 PROTEIN, HUMAN; DNA BINDING PROTEIN; PALMITIC ACID DERIVATIVE; REGULATORY FACTOR X TRANSCRIPTION FACTORS; SCD1 PROTEIN, HUMAN; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; LIPOTOXICITY; MEMBRANE FLUIDITY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; DRUG EFFECTS; ENDOPLASMIC RETICULUM; HEPG2 CELL LINE; METABOLISM; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

RICE STRIPE VIRUS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HEP G2 CELLS; HUMANS; NEOPLASMS; PALMITATES; REACTIVE OXYGEN SPECIES; STEAROYL-COA DESATURASE; STILBENES; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 84919340292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113929     Document Type: Article

References (55)

1. Eitel K, Staiger H, Brendel MD, Brandhorst D, Bretzel RG, et al. (2002) Different role of saturated and unsaturated fatty acids in β-cell apoptosis. Biochem Biophys Res Commun 299: 853-856.
2. Morgan NG, Dhayal S, Diakogiannaki E, Welters HJ (2008) The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic beta-cells. Biochem Soc Trans 36: 905-908.
3. Kong JY, Rabkin SW (2000) Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: Prevention by cyclosporin A. Biochim Biophys Acta - Mol Cell Biol Lipids. 1485: 45-55.
4. Wei Y, Wang D, Topczewski F, Pagliassotti MJ (2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291: E275-E281.
5. Zhang L, Seitz LC, Abramczyk AM, Chan C (2010) Synergistic effect of cAMP and palmitate in promoting altered mitochondrial function and cell death in HepG2 cells. Exp Cell Res 316: 716-727.
6. Kim J-E, Song SE, Kim Y-W, Kim J-Y, Park S-C, et al. (2010) Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. J Endocrinol 207: 35-44.
7. Pfaffenbach KT, Gentile CL, Nivala AM, Wang D, Wei Y, et al. (2010) Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am J Physiol Endocrinol Metab 298: E1027-E1035.
8. Ibrahim SH, Akazawa Y, Cazanave SC, Bronk SF, Elmi NA, et al. (2011) Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. J Hepatol 54: 765-772.
9. Kitamura M (2011) Control of NF-κB and inflammation by the unfolded protein response. Int Rev Immunol 30: 4-15.
10. Santos CXC, Tanaka LY, Wosniak J, Laurindo FRM (2009) Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 11: 2409-2427.
11. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, et al. (2004) CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18: 3066-3077.
12. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21: 1249-1259.
13. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271-274.
14. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, et al. (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666.
15. Yoon DH, Kwon OY, Mang JY, Jung MJ, Kim DY, et al. (2011) Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells. Biochem Biophys Res Commun 414: 49-52.
16. Li Y, Xu S, Giles A, Nakamura K, Lee JW, et al. (2011) Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J 25: 1664-1679.
17. Wang FM, Galson DL, Roodman GD, Ouyang H (2011) Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival xbp1 signaling in human multiple myeloma cells. Exp Hematol 39: 999-1006.
18. Liu BQ, Gao YY, Niu XF, Xie JS, Meng X, et al. (2010) Implication of unfolded protein response in resveratrol-induced inhibition of K562 cell proliferation. Biochem Biophys Res Commun 391: 778-782.
19. Lin C-L, Huang H-C, Lin J-K (2007) Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res 48: 2334-2343.
20. Wang GL, Fu YC, Xu WC, Feng YQ, Fang SR, et al. (2009) Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun 380: 644-649.
21. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
22. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M (2008) Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 295: G833-G842.
23. Jang M, Cai L, Udeani GO, Slowing K V, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
24. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, et al. (2001) Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22: 1633-1639.
25. Park JW, Choi YJ, Jang MA, Lee YS, Jun DY, et al. (2001) Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett 163: 43-49.
26. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, et al. (2006) Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5: 621-629.
27. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61.
28. Young CD, Anderson SM (2008) Sugar and fat - that's where it's at: metabolic changes in tumors. Breast Cancer Res 10: 202.
29. Swinnen J V., Van Veldhoven PP, Timmermans L, De Schrijver E, Brusselmans K, et al. (2003) Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem Biophys Res Commun 302: 898-
30. Chajès V, Lanson M, Fetissof F, Lhuillery C, Bougnoux P (1995) Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties. Int J Cancer 63: 169-175.
31. Riboni L, Ghidoni R, Sonnino S, Omodeo-Salè F, Gaini SM, et al. (1984) Phospholipid content and composition of human meningiomas. Neurochem Pathol 2: 171-188.
32. Szachowicz-Petelska B, Sulkowski S, Figaszewski ZA (2007) Altered membrane free unsaturated fatty acid composition in human colorectal cancer tissue. Mol Cell Biochem 294: 237-242.
33. Listenberger LL, Han X, Lewis SE, Cases S, Farese R V, et al. (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100: 3077-3082.
34. Chen L, Smith L, Wang Z, Smith JB (2003) Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination. Mol Pharmacol 64: 334-345.
35. De la Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35: 1156-1160.
36. Peter A, Weigert C, Staiger H, Machicao F, Schick F, et al. (2009) Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58: 1757-1765.
37. Minville-Walz M, Pierre A-S, Pichon L, Bellenger S, Fèvre C, et al. (2010) Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One 5: e14363.
38. Kim S, Jin Y, Choi Y, Park T (2011) Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 81: 1343-1351.
39. Chen S, Xiao X, Feng X, Li W, Zhou N, et al. (2012) Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J Nutr Biochem 23: 1100-1112.
40. Lee AS (2007) GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67: 3496-3499.
41. Luo J, Solimini NL, Elledge SJ (2009) Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction. Cell 138: 807.
42. Wang G, Yang ZQ, Zhang K (2010) Endoplasmic reticulum stress response in cancer: Molecular mechanism and therapeutic potential. Am J Transl Res 2: 65-74.
43. Wang C, Rajput S, Watabe K, Liao DF, Cao D (2010) Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed) 2: 515-526.
44. Kuhajda FP (2006) Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 66: 5977-5980.
45. Roongta U V, Pabalan JG, Wang X, Ryseck R-P, Fargnoli J, et al. (2011) Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res 9: 1551-1561.
46. Strittmatter P, Spatz L, Corcoran D, Rogers MJ, Setlow B, et al. (1974) Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci U S A 71: 4565-4569.
47. Miyazaki M, Bruggink SM, Ntambi JM (2006) Identification of mouse palmitoyl-coenzyme A Delta9-desaturase. J Lipid Res 47: 700-704.
48. Ariyama H, Kono N, Matsuda S, Inoue T, Arai H (2010) Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem 285: 22027-22035.
49. Thörn K, Hovsepyan M, Bergsten P (2010) Reduced levels of SCD1 accentuate palmitate-induced stress in insulin-producing β-cells. Lipids Health Dis 9: 108.
50. Mason P, Liang B, Li L, Fremgen T, Murphy E, et al. (2012) SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One 7: e33823.
51. Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, et al. (2006) Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res 47: 2726-2737.
52. Brittes J, Lucio M, Nunes C, Lima JLFC, Reis S (2010) Effects of resveratrol on membrane biophysical properties: Relevance for its pharmacological effects. Chem Phys Lipids 163: 747-754.
53. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32: 1377-1382.
54. Boocock DJ, Patel KR, Faust GES, Normolle DP, Marczylo TH, et al. (2007) Quantitation of transresveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Anal Technol Biomed Life Sci 848:
55. Mayer CM, Belsham DD (2010) Palmitate attenuates insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5′ monophosphate-activated protein kinase activation. Endocrinology 151: 576-585.